Antiviral Drug Development: Identification and Acquisition of Chemicals and Drugs
Final rept. 19 Jun 89-18 Dec 90,
BIOLOGICAL RESEARCH FACULTY AND FACILITY INC IJAMSVILLE MD
Pagination or Media Count:
During this contract period the following objectives were achieved 1 Enhanced the database on Antiviral Drug Information System ADIS by the addition of critical functions including report generators and data loaders. 2 Received and registered over 2,900 compounds during the contract period. 3 Received more than 32,000 in vitro test results and incorporated them into the database. 4 A total of 4,249 samples were sent for testing. 5 Over 430 compounds were confirmed to be active in vitro. The Biological Research Faculty and Facility, Inc. BRFF has been able to continue expansion of elements of the antiviral drug development program centered at the U.S. Army Medical Research Institute of Infectious Diseases USAMRIID. USAMRIID, a laboratory within the United States Army Medical Research and Development Command, provides the only research and development effort to discover antiviral drug candidates for use against virus-induced diseases of particular interest to DOD.
- Medicine and Medical Research